MAPT and Alzheimer disease: Using this method, our group previously studied human post-mortem brain samples from Alzheimer’s disease and Parkinson’s disease patients, as well as conditioned media samples from cerebral organoid models,7,35,36 characterizing the Aβ, tau and aSyn aggregates in these samples.